5F-CUMYL-PINACA (SGT-25) – High-Impact Synthetic Cannabinoid Research Reference
Product 5F-CUMYL-PINACA (SGT-25) for sale
5F-CUMYL-PINACA (SGT-25) is a fluorinated indazole-3-carboxamide synthetic cannabinoid that has played a significant role in forensic toxicology, analytical chemistry, and regulatory surveillance. Due to its appearance in seized-material casework and its close structural relationship to other CUMYL-based cannabinoids, SGT-25 remains an important reference compound for laboratories validating detection methods and maintaining accurate spectral libraries.
⚠️ For analytical, educational, and research purposes only. Not for human or animal consumption.
1. Compound Summary
5F-CUMYL-PINACA, also known as SGT-25, belongs to the CUMYL-PINACA family of indazole cannabinoids. The 5-fluoropentyl side chain distinguishes it from non-fluorinated analogues and contributes to its frequent inclusion in comparative analytical studies.
In laboratory environments, SGT-25 is commonly referenced to:
Differentiate fluorinated vs non-fluorinated PINACA analogues
Support trend analysis in new psychoactive substances (NPS)
Improve inter-laboratory reproducibility
2. Chemical & Technical Profile
Compound Name: 5F-CUMYL-PINACA
Alternative Name: SGT-25
Chemical Class: Indazole-3-carboxamide synthetic cannabinoid
Structural Group: CUMYL-PINACA derivatives
Typical Analytical Platforms: LC-MS/MS, GC-MS, HRMS
This page intentionally excludes synthesis routes, dosage data, or commercial guidance.
3. Research & Analytical Applications
5F-CUMYL-PINACA (SGT-25) is widely cited in professional research contexts, including:
Forensic toxicology confirmations
LC-MS/MS method development and validation
High-resolution mass spectrometry (HRMS) profiling
GC-MS spectral library benchmarking
Retrospective NPS trend analysis
Cross-analogue differentiation studies
Because many CUMYL-based cannabinoids share similar fragmentation patterns, SGT-25 is often used to verify selectivity and specificity in analytical workflows.
4. Regulatory & Legal Context
In most jurisdictions, 5F-CUMYL-PINACA is classified as a controlled substance or analogue under national drug legislation. Legal handling is generally limited to authorized and licensed entities.
Typical authorized settings include:
Government and customs laboratories
Accredited forensic and toxicology labs
Universities with regulatory and ethics approval
Public-health and regulatory research agencies
All work must comply with local laws, permits, and institutional policies.
5. Quality & Documentation Standards – Buy Quality 5F-CUMYL-PINACA (SGT-25)
Laboratories referencing SGT-25 usually operate under strict quality frameworks. Best practices include:
Research-use-only designation
Controlled documentation and traceability
Secure storage and access logs
Alignment with ISO/IEC or equivalent standards
These practices ensure data reliability, audit readiness, and methodological consistency.
6. Storage & Laboratory Handling
General laboratory considerations for handling reference cannabinoids include:
Secure, access-controlled storage
Stable environmental conditions
PPE usage according to institutional SOPs
Disposal via approved hazardous-waste channels
Such controls help preserve analytical stability and ensure compliance.
7. Eligible Institutions
This page is informational only.
Reference material on 5F-CUMYL-PINACA (SGT-25) is intended for:
Forensic and analytical laboratories
Academic research institutions
Government and regulatory bodies
8. Internal & External References
Synthetic Cannabinoid Research Resources
Laboratory Compliance & Documentation
EMCDDA – Synthetic Cannabinoids Monitoring
UNODC – Early Warning Advisory on NPS
WHO – Synthetic Cannabinoids Overview
9. SGT-25 for sale at Wholesale Prices
5F-CUMYL-PINACA (SGT-25) is referenced solely for analytical, forensic, and educational research.
It is not approved for medical, veterinary, or recreational use.
5F-CUMYL-PINACA SGT-25
Handling is restricted to authorized institutions in compliance with applicable laws.




Reviews
There are no reviews yet.